文献速递心境障碍会诊联络精神医学

简短人际心理治疗对孕期抑郁的随机临床试验

Effect of Brief Interpersonal Therapy on Depression During Pregnancy: A Randomized Clinical Trial.
PubMed 文献 · JAMA Psychiatry · 2023-01-01

这项前瞻性、评估者盲法的随机临床试验在产科门诊招募234名孕期抑郁症状升高的成人孕妇,比较简短人际心理治疗(IPT)与增强常规护理(EUC)。结果显示IPT组抑郁症状改善更显著,且至妊娠末期重性抑郁障碍(MDD)比例显著低于EUC组(6.1% vs 26.1%)。

要点

  • 简短IPT可显著改善孕期抑郁症状,效应量d=0.57(95%CI 0.22-0.91)。
  • 至妊娠末期,IPT组MDD比例6.1%,EUC组26.1%,OR=4.99(95%CI 2.08-11.97)。
  • 简短IPT是孕期抑郁安全有效的干预,可考虑在产科门诊推广。

核心结论

  • 在种族、民族和社会经济背景多样的孕妇中,简短IPT相比EUC显著降低孕期抑郁症状和MDD诊断率。

研究设计与样本

  • 前瞻性、评估者盲法随机临床试验(Care Project),2017年7月至2021年8月在产科门诊招募234名孕期抑郁筛查症状升高的成人孕妇,随机分配至IPT组(115人)或EUC组(119人),进行意向性分析。

主要发现

  • 20项症状清单评分:IPT组从基线26.7(SD 1.14)降至13.6(SD 1.40),EUC组从27.1(SD 1.12)降至23.5(SD 1.34),组间效应量d=0.57(95%CI 0.22-0.91)。
  • 爱丁堡产后抑郁量表评分:IPT组从11.4(SD 0.38)降至5.4(SD 0.57),EUC组从11.5(SD 0.37)降至7.6(SD 0.55),组间效应量d=0.40(95%CI 0.06-0.74)。
  • 妊娠末期MDD比例:IPT组7人(6.1%),EUC组31人(26.1%),OR=4.99(95%CI 2.08-11.97)。

临床怎么用

  • 对于产科门诊筛查出孕期抑郁症状升高的孕妇,可考虑提供简短IPT(含参与会谈和8次主动会谈)作为安全有效的治疗选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Prenatal depression is prevalent with negative consequences for both the mother and developing fetus. Brief, effective, and safe interventions to reduce depression during pregnancy are needed. OBJECTIVE: To evaluate depression improvement (symptoms and diagnosis) among pregnant individuals from diverse backgrounds randomized to brief interpersonal psychotherapy (IPT) vs enhanced usual care (EUC). DESIGN, SETTING, AND PARTICIPANTS: A prospective, evaluator-blinded, randomized clinical trial, the Care Project, was conducted among adult pregnant individuals who reported elevated symptoms during routine obstetric care depression screening in general practice in obstetrics and gynecology (OB/GYN) clinics. Participants were recruited between July 2017 and August 2021. Repeated measures follow-up occurred across pregnancy from baseline (mean [SD], 16.7 [4.2] gestational weeks) through term. Pregnant participants were randomized to IPT or EUC and included in intent-to-treat analyses. INTERVENTIONS: Treatment comprised an engagement session and 8 active sessions of brief IPT (MOMCare) during pregnancy. EUC included engagement and maternity support services. MAIN OUTCOMES AND MEASURES: Two depression symptom scales, the 20-item Symptom Checklist and the Edinburgh Postnatal Depression Scale, were assessed at baseline and repeatedly across pregnancy. Structured Clinical Interview for DSM-5 ascertained major depressive disorder (MDD) at baseline and the end of gestation. RESULTS: Of 234 participants, 115 were allocated to IPT (mean [SD] age, 29.7 [5.9] years; 57 [49.6%] enrolled in Medicaid; 42 [36.5%] had current MDD; 106 [92.2%] received intervention) and 119 to EUC (mean [SD] age, 30.1 [5.9] years; 62 [52.1%] enrolled in Medicaid; 44 [37%] had MDD). The 20-item Symptom Checklist scores improved from baseline over gestation for IPT but not EUC (d = 0.57; 95% CI, 0.22-0.91; mean [SD] change for IPT vs EUC: 26.7 [1.14] to 13.6 [1.40] vs 27.1 [1.12] to 23.5 [1.34]). IPT participants more rapidly improved on Edinburgh Postnatal Depression Scale compared with EUC (d = 0.40; 95% CI, 0.06-0.74; mean [SD] change for IPT vs EUC: 11.4 [0.38] to 5.4 [0.57] vs 11.5 [0.37] to 7.6 [0.55]). MDD rate by end of gestation had decreased significantly for IPT participants (7 [6.1%]) vs EUC (31 [26.1%]) (odds ratio, 4.99; 95% CI, 2.08-11.97). CONCLUSIONS AND RELEVANCE: In this study, brief IPT significantly reduced prenatal depression symptoms and MDD compared with EUC among pregnant individuals from diverse racial, ethnic, and socioeconomic backgrounds recruited from primary OB/GYN clinics. As a safe, effective intervention to relieve depression during pregnancy, brief IPT may positively affect mothers' mental health and the developing fetus. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03011801.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Hankin BL, Demers CH, Hennessey EP, et al. Effect of Brief Interpersonal Therapy on Depression During Pregnancy: A Randomized Clinical Trial. JAMA Psychiatry. 2023. PMID: 37074698. doi:10.1001/jamapsychiatry.2023.0702

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。